These compounds may interact with:
Tyrosine-protein kinase ABL1
Potentially involved in: cancer; chronic myeloid leukemia; immune system cancer; lymphoid leukemia; kidney cancer; carcinoma; polycythemia vera; thrombocytosis; hypereosinophilic syndrome; adenocarcinoma; esophageal neoplasms; fatigue; fever; myeloid leukemia, chronic; leukocytosis; liver neoplasms; myeloproliferative disease; neoplasms, experimental; precancerous conditions; splenomegaly
Disease data sourced from Pharos.